Patrick M. O'Connor

Patrick M. O'Connor, Ph.D. is a distinguished expert in cancer pharmacology with extensive experience in pharmaceutical and biotechnology sectors. Currently serving as Co-Founder, Chief Scientific Officer, and Board Member at Selexagen Therapeutics, Inc. since 2008, O'Connor also contributes as a Senior Editor at Cancer Research and as a Scientific Advisory Board Member for several organizations, including Molecular Response Laboratories, Deciphera Pharmaceuticals, and Eclipse Therapeutics. Previous roles include significant leadership positions at Halozyme Therapeutics, Inc., Ardea Biosciences, and Pfizer/Agouron, where O'Connor served as VP of Oncology Research. With a Doctor of Philosophy degree in Cancer Pharmacology from The University of Manchester, obtained in 1988, O'Connor has a long-standing commitment to advancing cancer research and therapeutic development.